Purchase Order N0017313P3560
Award Date 7/10/14
Potential Completion Date 7/9/15
Potential Value $15K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
San Diego, CA 92121, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Office of Naval Research awarded a $15,965 firm fixed-price purchase order to Illumina, Inc. for MiSeq Annual Service on July 10, 2015, with completion scheduled for July 9, 2016. The contract, which did not utilize a set-aside designation, covers maintenance and support services for Illumina's MiSeq DNA sequencing instrument at the contractor's San Diego, California location. Illumina is a leading biotechnology company specializing in genetic sequencing and genomic analysis technologies,...
- The U.S. Navy's Bureau of Medicine and Surgery awarded a $98,929.70 firm fixed-price purchase order to Illumina, Inc. for a MiSeq i100 Plus System on September 11, 2025. The contract, which originated from a sole-source Special Notice issued by the Naval Health Research Center in San Diego, covers the procurement of the advanced DNA sequencing instrument along with associated installation and operational qualification services. The award was justified under 10 U.S.C. 3204(a)(1) citing the...
- This firm fixed-price purchase order contract was awarded by the Department of the Navy's Bureau of Medicine and Surgery to Illumina, Inc., a manufacturer of sequencing and genomic analysis solutions. The contract, valued at $98,450.40, is to provide the agency with TruSeq Nano DNA Kits and MiSeq Reagent Kit V2 for genomic sequencing and analysis. This appears to be a delivery order under a larger Indefinite Delivery Contract worth up to $3.3 million that supports the Navy's nucleic acid...
- This is a firm-fixed-price purchase order awarded by the Naval Medical Research Command to Illumina, Inc., a for-profit manufacturer of genomic sequencing technologies. The requirement is for a MiSeq i100 Plus System, a specialized DNA/RNA sequencing instrument. The $90,997.20 contract has an ultimate completion date of July 30, 2025. Illumina is a prime contractor providing a range of genomic sequencing platforms, reagents, consumables, and maintenance services to multiple federal civilian...
- This is a firm fixed price purchase order contract awarded by the Naval Sea Systems Command to Illumina, Inc. to provide a MiSeq DNA Sequencer for $111,782.23. The contract has no set-aside designation. Illumina is a manufacturer of sequencing and array-based solutions for genetic and genomic analysis, and has previously provided various sequencing systems, reagents, and services to support research and diagnostics across multiple federal agencies. This award is likely part of Illumina's...
- The Office of Naval Research awarded a $5,675.74 firm fixed-price purchase order to Illumina, Inc. for laboratory supplies on May 5, 2017, with an ultimate completion date of August 3, 2017. The contract, issued without a set-aside designation, will be performed in San Diego, California, where Illumina maintains its headquarters. This purchase order represents a routine procurement of laboratory consumables and supplies from the biotechnology company, which specializes in genetic sequencing...
- This federal contract award was made by the Department of the Navy Bureau of Medicine and Surgery to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The $119,742.91 firm fixed price purchase order is for a MiSeq System, related reagents, and support services to be performed in San Diego, CA. The contract does not have a set-aside designation. The award was made on a sole source basis to Illumina, as the provider of the proprietary...
- This firm fixed-price purchase order was awarded by the Department of the Navy Bureau of Medicine and Surgery to Illumina, Inc., a manufacturer of genomic sequencing systems and reagents. The $116,503.92 contract is for the delivery of undisclosed sequencing products and services to support the agency's mission. Illumina has an Indefinite Delivery Contract worth up to $3.3 million with the Navy for providing reagents and controls for various Illumina sequencing platforms used by the Naval...
- The Office of Naval Research awarded a $16,302 firm fixed-price purchase order to Illumina, Inc. for reagent kits on September 26, 2013, with completion targeted for October 26, 2013. The contract, issued without a set-aside designation, will be performed in San Diego, California. Illumina is a biotechnology company specializing in genetic sequencing and genomic analysis technologies, providing DNA and RNA sequencing instruments, reagents, consumables, and bioinformatics software to federal...
- This is a firm-fixed-price purchase order contract awarded by the U.S. Navy Bureau of Medicine and Surgery to Illumina, Inc., a manufacturer of genetic sequencing instruments and reagents. The contract is for the provision of one MiSeq System and a 12-month MiSeq Silver Support Plan, valued at $88,357.50. The contract was awarded on a sole-source basis under the authority of 10 U.S.C. 2304(c)(1), as the Naval Health Research Center requires Illumina's proprietary MiSeq technology for their...